Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor

Journal of Toxicological Sciences

Volumn 33, Issue 3, 2008, Pages 269-276

  Nakanishi, Tsuyoshi ^a,b  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Aromatase; Endocrine disruptor; Organotin; Peroxisome proliferator activated receptor (PPAR) ; Retinoid X receptor (RXR)

Indexed keywords

ANDROGEN; AROMATASE INHIBITOR; CELL NUCLEUS RECEPTOR; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN; ORGANOTIN COMPOUND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; TESTOSTERONE 17BETA DEHYDROGENASE; TRIBUTYLTIN; TRIPHENYLTIN;

BIOSYNTHESIS; CELL DISRUPTION; CHORIOCARCINOMA; ENDOCRINE FUNCTION; ENDOCRINE SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPOSURE; GASTROPOD; GENE EXPRESSION; GENETICS; HUMAN; INVERTEBRATE; NONHUMAN; OVARY; PLACENTA; REVIEW; SEXUAL DYSFUNCTION; TOXICITY; WILDLIFE;

GASTROPODA; INVERTEBRATA; MAMMALIA; RODENTIA;

EID: 48849108032     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.33.269     Document Type: Review

References (59)

1. Adeeko, A., Li, D., Forsyth, D.S., Casey, V., Cooke, G.M., Barthelemy, J., Cyr, D.G., Trasler, J.M., Robaire, B. and Hales, B.F. (2003): Effects of in utero tributyltin chloride exposure in the rat on pregnancy outcome. Toxicol. Sci., 74, 407-415.
2. Aranda, A. and Pascual, A. (2001): Nuclear hormone receptors and gene expression. Physiol. Rev., 81, 1269-1304.
3. Bamberger, A.M., Ezzat, S., Cao, B., Wong, M., Parker, K.L., Schulte, H.M. and Asa, S.L. (1996): Expression of steroidogenic factor-1 (SF-1) mRNA and protein in the human placenta. Mol. Hum. Reprod., 2, 457-461.
4. Bardot, O., Aldridge, T.C., Latruffe, N. and Green, S. (1993): PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem. Biophys. Res. Commun., 192, 37-45.
5. Bettin, C., Oehlmann, J. and Stroben, E. (1996): TBT-induced imposex in marine neogastropods is mediated by an increasing androgen level. Helgol. Meeresunters., 50, 299-317.
6. Boyer, I.J. (1989): Toxicity of dibutyltin, tributyltin and other organotin compounds to humans and to experimental animals. Toxicology, 55, 253-298.
7. Bulun, S.E., Sebastian, S., Takayama, K., Suzuki, T., Sasano, H. and Shozu, M. (2003): The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J. Steroid Biochem. Mol. Biol., 86, 219-224.
8. Castro, L.F., Lima, D., Machado, A., Melo, C., Hiromori, Y., Nishikawa, J., Nakanishi, T., Reis-Henriques, M.A. and Santos, M.M. (2007): Imposex induction is mediated through the Retinoid X Receptor signalling pathway in the neogastropod Nucella lapillus. Aquat Toxicol., 85, 57-66.
9. Chambon, P. (1996): A decade of molecular biology of retinoic acid receptors. FASEB J., 10, 940-954.
10. Chuang, K.H., Lee, Y.F., Lin, W.J., Chu, C.Y., Altuwaijri, S., Wan, Y.J. and Chang, C. (2005): 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor. Mol. Endocrinol., 19, 1200-1212.
11. Cooke, G.M. (2002): Effect of organotins on human aromatase activity in vitro. Toxicol. Lett., 126, 121-130.
12. Doering, D.D., Steckelbroeck, S., Doering, T. and Klingmüller, D. (2002): Effects of butyltins on human 5α-reductase type 1 and type 2 activity. Steroids, 67, 859-867.
13. Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A.G., Myskowski, P., Crowley, C. and Yocum, R.C. (2001): Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results. J. Clin. Oncol., 19, 2456-2471.
14. Escriva, H., Safi, R., Hänni, C., Langlois, M.C., Saumitou-Laprade, P., Stehelin, D., Capron, A., Pierce, R. and Laudet, V. (1997): Ligand binding was acquired during evolution of nuclear recep-tors. Proc. Natl. Acad. Sci. USA, 94, 6803-6808.
15. Escriva, H., Delaunay, F. and Laudet, V. (2000): Ligand binding and nuclear receptor evolution. Bioessays, 22, 717-727.
16. Fan, W., Yanase, T., Morinaga, H., Mu, Y.M., Nomura, M., Okabe, T., Goto, K., Harada, N. and Nawata, H. (2005): Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB. Endocrinology, 146, 85-92.
17. Fent, K. (1996): Ecotoxicology of organotin compounds. Crit Rev. Toxicol., 26, 3-117.
18. Forman, B.M., Umesono, K., Chen, J. and Evans, R.M. (1995): Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell, 81, 541-550.
19. Germain, P., Iyer, J., Zechel, C. and Gronemeyer, H. (2002): Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature, 415, 187-192.
20. Giguere, V. (1994): Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr. Rev., 15, 61-79.
21. Grün, F., Watanabe, H., Zamanian, Z., Maeda, L., Arima, K., Cubacha, R., Gardiner, D.M., Kanno, J., Iguchi, T. and Blumberg, B. (2006): Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol. Endocrinol., 20, 2141-2155.
22. Heidrich, D.D., Steckelbroeck, S. and Klingmuller, D. (2001): Inhibition of human cytochrome P450 aromatase activity by butyltins. Steroids, 66, 763-769.
23. Horiguchi, T., Shiraishi, H., Shimizu, M. and Morita, M. (1997): Effects of triphenyltin chloride and five other organotin compounds on the development of imposex in the rock shell, Thais clavigera. Environ. Pollut., 95, 85-91.
24. Issemann, I., Prince, R.A., Tugwood, J.D. and Green, S. (1993): The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J. Mol. Endocrinol., 11, 37-47.
25. Kanayama, T., Mamiya, S., Nishihara, T. and Nishikawa, J. (2003): Basis of a high-throughput method for nuclear receptor ligands. J. Biochem. (Tokyo), 133, 791-797.
26. Kanayama, T., Kobayashi, N., Mamiya, S., Nakanishi, T. and Nishikawa, J. (2005): Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor γ/retinoid X receptor pathway. Mol. Pharmacol., 67, 766-774.
27. Kannan, K., Senthilkumar, K. and Giesy, J.P. (1999): Occurrence of butyltin compounds in human blood. Environ. Sci. Technol., 33, 1776-1779.
28. Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A. and Evans, R.M. (1992): Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature, 358, 771-774.
29. Laffitte, B.A., Kast, H.R., Nguyen, C.M., Zavacki, A.M., Moore, D.D. and Edwards, P.A. (2000): Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor. J. Biol. Chem., 275, 10638-10647.
30. Lee, R.F. (1985): Metabolism of tributyltin oxide by crabs, oysters and fish. Mar. Environ. Res., 17, 145-148.
31. Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., Wilkison, W.O., Willson, T.M. and Kliewer, S.A. (1995): An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem., 270, 12953-12956.
32. Liu, S., Ogilvie, K.M., Klausing, K., Lawson, M.A., Jolley, D., Li, D., Bilakovics, J., Pascual, B., Hein, N., Urcan, M. and Leibowitz, M.D. (2002): Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. Endocrinology, 143, 2880-2885.
33. Lo, S., Allera, A., Albers, P., Heimbrecht, J., Jantzen, E., Klingmuller, D. and Steckelbroeck, S. (2003): Dithioerythritol (DTE) prevents inhibitory effects of triphenyltin (TPT) on the key enzymes of the human sex steroid hormone metabolism. J. Steroid Biochem. Mol. Biol., 84, 569-576.
34. Matthiessen, P. and Gibbs, P.E. (1998): Critical appraisal of the evidence for tributyltin-mediated endocrine disruption in mollusks. Environ. Toxicol. Chem., 17, 37-43.
35. McVey, M.J. and Cooke, G.M. (2003): Inhibition of rat testis microsomal 3β-hydroxysteroid dehydrogenase activity by tributyltin. J. Steroid Biochem. Mol. Biol., 86, 99-105.
36. Michael, M.D., Kilgore, M.W., Morohashi, K. and Simpson, E.R. (1995): Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J. Biol. Chem., 270, 13561-13566.
37. Mu, Y.M., Yanase, T., Nishi, Y., Waseda, N., Oda, T., Tanaka, A., Takayanagi, R. and Nawata, H. (2000): Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem. Biophys. Res. Commun., 271, 710-713.
38. Mu, Y.M., Yanase, T., Nishi, Y., Takayanagi, R., Goto, K. and Nawata, H. (2001): Combined treatment with specific ligands for PPARγ:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol. Cell. Endocrinol., 181, 239-248.
39. Mukherjee, R., Davies, P.J., Crombie, D.L., Bischoff, E.D., Cesario, R.M., Jow, L., Hamann, L.G., Boehm, M.F., Mondon, C.E., Nadzan, A.M., Paterniti, J.R., Jr. and Heyman, R.A. (1997): Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature, 386, 407-410.
40. Nakanishi, T., Kohroki, J., Suzuki, S., Ishizaki, J., Hiromori, Y., Takasuga, S., Itoh, N., Watanabe, Y., Utoguchi, N. and Tanaka, K. (2002): Trialkyltin compounds enhance human CG secretion and aromatase activity in human placental choriocarcinoma cells. J. Clin. Endocrinol. Metab., 87, 2830-2837.
41. Nakanishi, T., Nishikawa, J., Hiromori, Y., Yokoyama, H., Koyanagi, M., Takasuga, S., Ishizaki, J., Watanabe, M., Isa, S., Utoguchi, N., Itoh, N., Kohno, Y., Nishihara, T. and Tanaka, K. (2005): Trialkyltin compounds bind retinoid X receptor to alter human placental endocrine functions. Mol. Endocrinol., 19, 2502-2516.
42. Nakanishi, T., Hiromori, Y., Yokoyama, H., Koyanagi, M., Itoh, N., Nishikawa, J. and Tanaka, K. (2006): Organotin compounds enhance 17β-hydroxysteroid dehydrogenase type I activity in human choriocarcinoma JAr cells: potential promotion of 17β-estradiol biosynthesis in human placenta. Biochem. Pharmacol., 71, 1349-1357.
43. Nishikawa, J., Mamiya, S., Kanayama, T., Nishikawa, T., Shiraishi, F. and Horiguchi, T. (2004): Involvement of the retinoid X receptor in the development of imposex caused by organotins in gastropods. Environ. Sci. Technol., 38, 6271-6276.
44. Ohno, S., Nakajima, Y. and Nakajin, S. (2005): Triphenyltin and Tributyltin inhibit pig testicular 17β-hydroxysteroid dehydrogenase activity and suppress testicular testosterone biosynthesis. Steroids, 70, 645-651.
45. Osada, S., Nishikawa, J., Nakanishi, T., Tanaka, K. and Nishihara, T. (2005): Some organotin compounds enhance histone acetyltransferase activity. Toxicol. Lett., 155, 329-335.
46. Rantakokko, P., Kuningas, T., Saastamoinen, K. and Vartiainen, T. (2006): Dietary intake of organotin compounds in Finland: a market-basket study. Food Addit Contain., 23, 749-756.
47. Saitoh, M., Yanase, T., Morinaga, H., Tanabe, M., Mu, Y.M., Nishi, Y., Nomura, M., Okabe, T., Goto, K., Takayanagi, R. and Nawata, H. (2001): Tributyltin or triphenyltin inhibits aromatase activity in the human granulosa-like tumor cell line KGN. Biochem. Biophys. Res. Commun., 289, 198-204.
48. Schuhnan, I.G., Shao, G. and Heyman, R.A. (1998): Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: intermolecular synergy requires only the PPARγ hormone-dependent activation function. Mol. Cell, Biol., 18, 3483-3494.
49. Sebastian, S. and Bulun, S.E. (2001): A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J. Clin. Endocrinol. Metab., 86, 4600-4602.
50. Simpson, E.R., Mahendroo, M.S., Means, G.D., Kilgore, M.W., Hinshelwood, M.M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C.R., Michael, M.D., Mendelson, C.R. and Bulun, S.E. (1994): Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev., 15, 342-355.
51. Simpson, E.R., Michael, M.D., Agarwal, V.R., Hinshelwood, M.M., Bulun, S.E. and Zhao, Y. (1997): Cytochromes P450 11: expression of the CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB J., 11, 29-36.
52. Sun, T., Zhao, Y., Mangelsdorf, D.J. and Simpson, E.R. (1998): Characterization of a region upstream of exon I.1 of the human CYP19 (aromatase) gene that mediates regulation by retinoids in human choriocarcinoma cells. Endocrinology, 139, 1684-1691.
53. Takahashi, S., Mukai, H., Tanabe, S., Sakayama, K., Miyazaki, T. and Masuno, H. (1999): Butyltin residues in livers of humans and wild terrestrial mammals and in plastic products. Environ. Pollut., 106, 213-218.
54. Thompson, P.D., Jurutka, P.W., Haussler, C.A., Whitfield, G.K. and Haussler, M.R. (1998): Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J. Biol. Chem., 273, 8483-8491.
55. Tontonoz, P., Hu, E. and Spiegelman, B.M. (1994): Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell, 79, 1147-1156.
56. Tsuda, T., Inoue, T., Kojima, M. and Aoki, S. (1995): Daily intakes of tributyltin and triphenyltin compounds from meals. J. AOAC Int., 78, 941-943.
57. Watanabe, H., Adachi, R., Hirayama, A., Kasahara, T. and Suzuki, K. (2003): Triphenyltin enhances the neutrophilic differentiation of promyelocytic HL-60 cells. Biochem. Biophys. Res. Commun., 306, 26-31.
58. Westin, S., Kurokawa, R., Nolte, R.T., Wisely, G.B., McInerney, E.M., Rose, D.W., Milburn, M.V., Rosenfeld, M.G. and Glass, C.K. (1998): Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature, 395, 199-202.
59. Yamabe, Y., Hoshino, A., Imura, N., Suzuki, T. and Himeno, S. (2000): Enhancement of androgen-dependent transcription and cell proliferation by tributyltin and triphenyltin in human prostate cancer cells. Toxicol. Appl. Pharmacol., 169, 177-184.